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Abstract
Introduction. Recent study results show that essential oils obtained from some plants have a strong bactericidal effect against 
many pathogenic microorganisms and therefore they may play a supportive role in the prevention and treatment of infections 
caused by Helicobacter pylori. infection with Helicobacter pylori is a suspected cause of rosacea, a chronic multi-phase inflam-
matory disease of the face, manifesting with vascular changes in the form of characteristic erythema. The purpose of this work 
was to present aromatherapy as a safe method supporting the treatment of rosacea induced by Helicobacter pylori.
Methods. The paper is a narrative review of the world scientific literature.
Results. Essential oils that exert an antimicrobial effect on Helicobacter pylori are presented. They penetrate the cell wall and 
cell membrane of the microorganisms, disturb the integrity of the structures, and lead to bacterial cell death.
Conclusions. The broad range of effects, rapidity of action, and efficacy of aromatherapy make it an effective weapon against 
Helicobacter pylori infections.
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Introduction
Rosacea is a chronic multi-phase inflammatory disease 
of the skin of face, frequently characterized by alternating 
periods of exacerbation and remission [1, 2]. The main symp-
tom of the condition is vascular changes in the form of ery-
thema [3]. Along with disease progression, secondary erup-
tions begin to appear on the erythematous background, such 
as telangiectasias, papules and pustules, oedema, and some-
times also soft tissue hypertrophy [4]. According to statistical 
data, rosacea affects 1–10% of the population, mainly from 
the 30–55-year age group [5].
in spite of many research studies performed to date, the 
etiopathogenesis of rosacea remains unclear [1, 6]. Accord-
ing to Górkiewicz-Petkow [7], the multi-phase nature of the 
condition is related to the contribution of various factors 
and various pathogenetic mechanisms at particular stages 
of the disease. Many authors, on the basis of experimental 
studies, suggest that the most important mechanisms par-
ticipating in the pathogenesis of rosacea are the following: 
disturbances of congenital immune response, vascular prob-
lems, and the effects of reactive oxygen species (RoS) and 
of protease enzymes [8–11]. Yamasaki and Gallo [12] un-
derline that inflammatory process induced by Helicobacter 
pylori may be a cause of this disease, as well. This infection is 
found in 30–40% of the North American population, 60–80% 
of the Central European population, 30–40% of the Western 
European population, and as many as 90% of people from 
developing countries [13, 14]. The bacterium is currently 
considered to be the most important factor inducing chronic 
and acute inflammatory conditions of the stomach and its 
presence significantly increases the risk of gastric and duo-
denal peptic ulcers development [15–17]. Helicobacter pylori 
resistance to gastric acid is possible owing to the presence of 
a urease enzyme that catalyses the reactions of urea break-
down into ammonia and carbon dioxide, thus neutralising 
the effects of gastric acid [18].
The results of recent clinical studies have shown the 
presence of anti-Helicobacter pylori antibodies in the serum 
of patients with rosacea. The antibodies were detected in 80% 
of patients who additionally experienced dyspeptic symp-
toms [19–21]. Furthermore, strains of varying virulence level 
were isolated among these bacteria. in type i bacteria, includ-
ing 60–80% of Helicobacter pylori strains, production of strongly 
immunogenic CagA protein of cytotoxic activity was observed. 
Besides, type i bacteria produce vacuolating cytotoxin VacA, 
whose secretion is synchronised with CagA translocation to 
gastric epidermal cells. in 67% of 60 rosacea patients with 
concomitant Helicobacter pylori infection, CagA (+) strain 
and elevated plasma levels of tumour necrosis factor  and 
interleukin 8 were present; in the control group, a CagA (+) 
strain was found in 32% of cases [21]. on the basis of these 
studies results, the virulent CagA (+) Helicobacter pylori 
strain was speculated to contribute to induction of rosacea 
symptoms through elevation of serum levels of some cyto-
kines [19, 22].
Another conception concerning the pathogenicity of Heli-
cobacter pylori assumes that the bacterium has the ability to 
increase the plasma levels of RoS and contributes to a re-
lease of proinflammatory cytokines in a mechanism depen-
dent on TLR2 and TLR4 receptors activation in epithelial 
cells of the gastric mucosa [19, 23, 24]. Subsequently, RoS 
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may contribute to the development of skin problems in differ-
ent ways, including, but not limited to, blocking tissue me-
talloproteinase inhibitors [25].
At present, various therapies are used in the treatment 
of Helicobacter pylori infection and some of them lead to 
the inhibition of bacterial growth or to the bacterium elimi-
nation [26, 27]. A treatment combining three drugs (two an-
tibiotics and an inhibitor of hydrochloric acid secretion in 
the stomach) provides highest efficacy, reaching 90%. Adverse 
effects are relatively frequent during the treatment (15–30% 
of cases) and include dysgeusia, nausea, vomiting, abdomi-
nal pains, and diarrhoea. The observation of growing resis-
tance of the bacterium to the applied antibiotics and de-
crease of treatment efficacy leads to continuous search for 
natural therapeutic agents that inhibit the microorganism 
[28]. Studies conducted in the recent years have shown 
that some plant-derived products, with low toxicity and rare 
side effects, exert a strong bactericidal effect against many 
pathogenic microorganisms and may have a supportive 
role in the prevention and treatment of infections triggered 
by Helicobacter pylori.
The purpose of this work was to present aromatherapy 
as a method supporting the treatment of rosacea induced 
by Helicobacter pylori.
Methods
The paper is a narrative review based on the search of 
the world scientific literature. Because of the low number of 
publications found in databases (Web of Science, PubMed, 
Medline, EBSCo, Scopus, Google Scholar, CiNAHL), the 
authors did not decide to perform a formal systematic review.
Aromatherapy
Aromatherapy consists in the use of natural essential oils 
obtained from plants with therapeutic properties for medi-
cal purposes [29, 30]. it belongs to natural medicine meth-
ods. Numerous benefits from its action on the human body 
make it more and more popular. The main forms of aroma-
therapy include massages, inhalations, and aromathera-
peutic baths [31].
Essential oils are not chemically uniform; in the majority 
of cases, they constitute mixtures of many organic compounds. 
These may include terpene hydrocarbons and their oxy-
genated derivatives, alcohols, aldehydes, ketones, organic 
acids, esters, and ethers [32]. Essential oils may enter the 
body in two ways [29, 33]:
1. Via the respiratory system. Along with the inspired air, 
aromatic molecules enter the circulation and then they reach 
internal organs and brain. Aromatic substances are detect-
ed by olfactory receptors located in the olfactory epithelium 
of the nasal cavity and from this point information is trans-
ferred to the olfactory bulb and then to higher levels of the 
nervous system.
2. Via the skin. The small dimensions of the compounds 
of essential oils enable them to penetrate the skin, mainly 
through hair follicles and sebaceous and sweat glands.
Ethical approval
The conducted research is not related to either human 
or animal use.
Results
This paper presents a suggestion to use aromatherapy 
in the treatment of rosacea; therefore, the presented es-
sential oils are limited to those that owing to their properties 
have an antimicrobial effect on Helicobacter pylori (Table 1). 
Being highly lipophilic, these compounds easily penetrate 
the cell wall and cell membrane of various microorganisms, 
disturbing the integrity of these structures and, finally, lead-
ing to death of bacterial cells [34, 35].
Discussion
Scientific reports inform that plant extracts containing 
several active secondary metabolites, including, but not limited 
to, flavonoids, tannins, glucosinolates, or terpene compounds, 
show strong bactericidal activity against many pathogenic 
microorganisms: among others, Helicobacter pylori. Six fla-
vonoid compounds have been isolated from a chloroform 
extract of Cistus laurifolius leaves. out of them, 3-methyl-
quercetin ether – isorhamnetin – appears to have the stron-
Table 1. Essential oils with antimicrobial effect [36–41]
English name Latin name Region of origin
Laurel-leaf cistus Cistus laurifolius Mediterranean Basin
Grapefruit Citrus paradisi Malay Archipelago
oregano Origanum vulgare Northern Africa, Europe, Asia
Thyme Thymus vulgaris Northern Africa, Europe
Tea tree Melaleuca alternifolia New South Wales
Lemongrass Cymbopogon citratus Mediterranean countries
Ginger Zingiber officinale Melanesia
Garlic Allium sativum Central Asia
Lavender Lavandula officinalis Canary islands, india
Rosemary Rosmarinus officinalis Mediterranean region
Carnation Dianthus Eurasia, Northern Africa
Lemon verbena Aloysia citrodora South America
Lemon balm Melissa officinalis Southern Europe, Asia
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gest activity against Helicobacter pylori, and quercetin 3,7-di-
methyl ether and kaempferol 3,7-dimethyl ether exert the 
weakest effect [37]. Cavallito and Bailey [36], in turn, showed 
the influence of grapefruit extract flavonoids (hesperidin, 
poncirin, and naringin, among others) on Helicobacter pylori 
growth. o’Gara et al. [42] studied the effect of essential oil 
obtained from grapefruit tree on Helicobacter pylori. They 
observed that this oil, at a concentration of 1000 μg/ml, had 
bactericidal effect on a strain of Helicobacter pylori after 
1-hour incubation. They obtained a similar result with 10-fold 
lower concentration (100 μg/ml) after 24-hour exposition. 
Minimal bactericidal concentrations for the 8 examined 
strains read after 24 hours ranged from 40 to > 100 μg/ml.
Strong inhibition of Helicobacter pylori growth was re-
vealed in screening tests of activity of essential oils obtained 
from a number of plants: wild carrot (Daucus carota), Ceylon 
cinnamon tree (Cinnamomum zeylanicum), winter savory 
(Satureja montana), true chamomile (Matricaria recutita), bitter 
orange (Citrus aurantium), spearmint (Mentha spicata), cloves 
(Eugenia caryophylata), field mint (Mentha arvensis), cam-
phor catnip (Nepeta camphorata), lemon balm (Melissa of-
ficinalis), peppermint (Mentha piperita), common sage (Salvia 
officinalis), manuka myrtle (Leptospermum scoparium), true 
cardamom (Elettaria cardamomum), coriander (Coriandrum 
sativum), fennel (Foeniculum vulgare), meridian fennel (Ca-
rum carvi), basil (Ocimum basilicum), and star anise (Illicium 
verum) [43]. Studies of other authors confirmed the efficacy 
of essential oil plants, including popular spices, in fighting 
Helicobacter pylori [38]. oregano oil and monolaurin (a sub-
stance obtained from coconut oil, containing monoglycer-
ides and fatty acids) administered alone or in combination 
effectively inhibited Helicobacter pylori growth, which sug-
gests that they may be useful in monotherapy or in combi-
nation with antibiotics [38]. Thyme water extracts have shown 
a strong inhibitory effect on Helicobacter pylori, as well [39]. 
Cermelli et al. [40], on the basis of their own studies, sug-
gested that thyme extracts might be used for preparation of 
a therapeutic composition inhibiting the growth of the dis-
cussed bacterium and decreasing urease activity. Similar 
activity was also found for oils from many commonly known 
and used plants, e.g. from ginger rhizome and from lemon 
balm. Experiments performed by other authors confirmed anti-
microbial activity of garlic oil, containing allicin as active sub-
stance [42]. its high efficacy against Helicobacter pylori was 
also reported [44, 45]. Bacteriostatic effects of rosemary, 
lavender, and tea tree leaf oils have been proved, too. in in vitro 
studies, lemongrass oil and lemon verbena oil appeared to 
be the most effective ones. They inhibit Helicobacter pylori 
growth already at very low concentrations (at the level of 
0.01%). According to investigators, the substance respon-
sible for the bactericidal effect on Helicobacter pylori is citral, 
the main component of these oils [41]. inhibition of Helico-
bacter pylori growth was also shown when eugenol (main 
component of the clove oil) and cinnamon aldehyde (ob-
tained from cinnamon bark) were used [46]. Numerous on-
going in vitro studies are promising and suggest a possibility 
to use these oils or some of their components in the treat-
ment of Helicobacter pylori infections. Their enormous advan-
tage is the fact that they remain active even in the strongly 
acidic environment of the stomach (pH 4–5). Furthermore, 
no resistance development to the examined essential oils 
was found in this microorganism [47].
Conclusions
owing to a wide range of various biological effects, aro-
matherapy may be a favourable alternative in the prevention 
and treatment of infections. Essential oils and their terpene 
components are proved to have antibacterial, antiviral, anti-
fungal, antiparasitic, and anti-inflammatory effects [40, 48–50]. 
despite the fact that numerous studies confirm the bacteri-
cidal impact of essential oils, they still remain in the shadow 
of pharmacological treatments and have only an adjunctive 
role. However, the broad range of effects, rapidity of action, 
and efficacy of aromatherapy make it an effective weapon 
against Helicobacter pylori infections. Therefore, aromather-
apy should be popularised with all its positive effects, en-
couraging researchers to continue investigation of this field 
of natural medicine [51, 52]. Further experiments will certainly 
contribute to the discovery of new aspects of aromatherapy.
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